ArticleClinical drug investigation2023

Sacubitril/Valsartan for Heart Failure with Preserved Ejection Fraction: A Cost-Effectiveness Analysis from the Perspective of the Chinese Healthcare System.

Zhe Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.